In the US, about 10.4% of individuals have experienced MDD in the last 12 months, and 20.6% have had it at some point in their lives. Psychopharmacology and psychotherapy modalities like cognitive behavioral therapy are among the first-line, empirically supported treatments for MDD. However, these treatments are frequently ineffective for treating depressive symptoms. What are recommended treatment plans and why?